Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis ; volume:37 ; number:6 ; day:24 ; month:4 ; year:2020 ; pages:2988-2998 ; date:6.2020
Advances in therapy ; 37, Heft 6 (24.4.2020), 2988-2998, 6.2020
- Creator
-
Hermans, Cedric
Marino, Renato
Lambert, Catherine
Mangles, Sarah
Sommerer, Patrick
Rives, Vincent
Maro, Geraldine
Malcangi, Giuseppe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-020-01300-6
- URN
-
urn:nbn:de:101:1-2020080121415336396414
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.05.2025, 4:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hermans, Cedric
- Marino, Renato
- Lambert, Catherine
- Mangles, Sarah
- Sommerer, Patrick
- Rives, Vincent
- Maro, Geraldine
- Malcangi, Giuseppe
- SpringerLink (Online service)
Other Objects (12)
Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers
De haemophilia
Perinatal Management of Haemophilia
Nerve Lesions in Haemophilia
Estimating the impact of improved management of haemophilia a on clinical outcomes and healthcare utilisation and costs
De Haemophilia : Diss. inaug. med.
Issues in pediatric haemophilia care
Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries
Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors
F.P.
F.P
FP
Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers
De haemophilia
Perinatal Management of Haemophilia
Nerve Lesions in Haemophilia
Estimating the impact of improved management of haemophilia a on clinical outcomes and healthcare utilisation and costs
De Haemophilia : Diss. inaug. med.
Issues in pediatric haemophilia care
Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries
Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors
F.P.
F.P
FP
Electroimmunoassay of Factor IX in the Detection of Haemophilia B Carriers
De haemophilia
Perinatal Management of Haemophilia
Nerve Lesions in Haemophilia
Estimating the impact of improved management of haemophilia a on clinical outcomes and healthcare utilisation and costs
De Haemophilia : Diss. inaug. med.
Issues in pediatric haemophilia care
Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries
Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors
F.P.
F.P